Details
Stereochemistry | ACHIRAL |
Molecular Formula | C18H18N2O4.Cl.Mn |
Molecular Weight | 416.738 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Cl-].[Mn+3].COC1=CC=CC(\C=N\CC\N=C\C2=C([O-])C(OC)=CC=C2)=C1[O-]
InChI
InChIKey=YUZJJFWCXJDFOQ-GAMUHHASSA-K
InChI=1S/C18H20N2O4.ClH.Mn/c1-23-15-7-3-5-13(17(15)21)11-19-9-10-20-12-14-6-4-8-16(24-2)18(14)22;;/h3-8,11-12,21-22H,9-10H2,1-2H3;1H;/q;;+3/p-3/b19-11+,20-12+;;
Molecular Formula | C18H18N2O4 |
Molecular Weight | 326.3465 |
Charge | -2 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 2 |
Optical Activity | NONE |
Molecular Formula | Mn |
Molecular Weight | 54.938 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
ETHYLBISIMINOMETHYLGUAIACOL MANGANESE CHLORIDE (EUK-134) is a synthetic manganese-porphyrin complex. It is a superoxide dismutase and catalase mimetic. EUK-134 can protect ischemically injured rat kidneys from ischemia-reperfusion syndrome when administered just before reperfusion. EUK-134 can markedly protect primary rat cortical neurons from hydrogen peroxide mediated oxidative stress. Treatment with EUK-134 prevented the force decrease and the actin modifications in pulmonary hypertension diaphragm bundles. EUK-134 is identified as a novel approach to attenuate cardiac hypertrophy and lends scope for the development of EUK-134 as a therapeutic agent in the management of human cardiovascular disease.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0004784 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8970624 |
|||
Target ID: GO:0004096 Sources: https://www.ncbi.nlm.nih.gov/pubmed/8970624 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Preventing | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
Mitochondrial catalase overexpressed transgenic mice are protected against lung fibrosis in part via preventing alveolar epithelial cell mitochondrial DNA damage. | 2016 Dec |
|
Direct effect of chronic hypoxia in suppressing large conductance Ca(2+)-activated K(+) channel activity in ovine uterine arteries via increasing oxidative stress. | 2016 Jan 15 |
|
Mitoprotective antioxidant EUK-134 stimulates fatty acid oxidation and prevents hypertrophy in H9C2 cells. | 2016 Sep |
|
RyR2-Mediated Ca(2+) Release and Mitochondrial ROS Generation Partake in the Synaptic Dysfunction Caused by Amyloid β Peptide Oligomers. | 2017 |
|
Superoxide dismutase/catalase mimetic EUK-134 prevents diaphragm muscle weakness in monocrotalin-induced pulmonary hypertension. | 2017 |
|
Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression. | 2017 Apr 10 |
|
Targeting hepatocellular carcinoma with piperine by radical-mediated mitochondrial pathway of apoptosis: An in vitro and in vivo study. | 2017 Jul |
|
Klotho, an antiaging molecule, attenuates oxidant-induced alveolar epithelial cell mtDNA damage and apoptosis. | 2017 Jul 1 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/8970624
Rat: a single injection at 0.2 mg/kg
Route of Administration:
Intravenous
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27514538
The possible role of EUK-134, a mitoprotective antioxidant, in the prevention of hypertrophy of H9C2 cells was examined. The cells were stimulated with phenylephrine (50 uM), and hypertrophy was assessed based on cell volume and expression of brain natriuretic peptide and calcineurin. Pretreatment with EUK-134 (10 uM) was effective in the prevention of hypertrophic changes in H9C2 cells, reduction of oxidative stress, and prevention of metabolic shift. EUK-134 treatment improved the oxidative status of mitochondria and reversed hypertrophy-induced reduction of mitochondrial membrane potential.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 20:10:54 UTC 2023
by
admin
on
Sat Dec 16 20:10:54 UTC 2023
|
Record UNII |
SM5YJ88LTU
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SM5YJ88LTU
Created by
admin on Sat Dec 16 20:10:54 UTC 2023 , Edited by admin on Sat Dec 16 20:10:54 UTC 2023
|
PRIMARY | |||
|
DTXSID801021732
Created by
admin on Sat Dec 16 20:10:54 UTC 2023 , Edited by admin on Sat Dec 16 20:10:54 UTC 2023
|
PRIMARY | |||
|
81065-76-1
Created by
admin on Sat Dec 16 20:10:54 UTC 2023 , Edited by admin on Sat Dec 16 20:10:54 UTC 2023
|
PRIMARY | |||
|
SM5YJ88LTU
Created by
admin on Sat Dec 16 20:10:54 UTC 2023 , Edited by admin on Sat Dec 16 20:10:54 UTC 2023
|
PRIMARY | |||
|
1373152
Created by
admin on Sat Dec 16 20:10:54 UTC 2023 , Edited by admin on Sat Dec 16 20:10:54 UTC 2023
|
PRIMARY | RxNorm |